Journal of pain and symptom management
-
J Pain Symptom Manage · Jun 2023
Clinical TrialLevorphanol as a Second Line Opioid in Cancer Patients Presenting to an Outpatient Supportive Care Center: An Open-Label Study.
Levorphanol is a potent opioid agonist and NMDA receptor blocker with minimal drug interactions, and there are few reports of its use in cancer patients. ⋯ This study provided preliminary data that cancer patients could be successfully rotated to levorphanol using an ORR of 8.5. Levorphanol was associated with improved pain and symptom control and was well- tolerated.
-
J Pain Symptom Manage · Jun 2023
Randomized Controlled TrialA sequential multiple assignment randomized trial of symptom management after chemotherapy.
Many cancer survivors experience a lingering symptom burden after chemotherapy. ⋯ The SMSH may represent a simple effective option for symptom management, adding TIPC only when there is no response to SMSH alone for people with elevated depression and multiple co-morbidities.
-
J Pain Symptom Manage · Jun 2023
Stigmatizing language expressed towards individuals with current or previous OUD who have pain and cancer: A qualitative study.
Stigma is known to impact the care of patients with opioid use disorder (OUD). ⋯ Healthcare provider stigma must be addressed as its effects are both quantitatively and qualitatively affecting patient care; in particular access to pain treatment. Continuity of care by known care providers may improve pain care for patients with cancer and OUD who are acutely hospitalized.
-
J Pain Symptom Manage · Jun 2023
The Team-based Serious Illness Care Program, a qualitative evaluation of implementation and teaming.
Earlier and more frequent serious illness conversations with patients allow clinical teams to better align care with patients' goals and values. Nonphysician clinicians often have unique perspectives and understanding of patients' wishes and are thus well-positioned to support conversations with seriously ill patients. The Team-based Serious Illness Care Program (SICP) at Stanford aimed to involve all care team members to support and conduct serious illness conversations with patients and their caregivers and families. ⋯ Team-based serious illness communication is viable and valuable, with a range of successful workflow and leadership approaches.